FDA Airs ‘Concerns’ Over IP Barriers

US Agency’s Patent Concerns Include Thickets, Product Hopping And Evergreening

 
• By Nielsen Hobbs
  
With a report due to Congress in January, Orange Book patent issues may find their way into user fee reauthorization legislation next year • Source: Nielsen Hobbs

More from Legal & IP

More from Generics Bulletin